Clinical Trial Update: Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating EVER001 for primary membranous nephropathy, focusing on efficacy, safety, pharmacokinetics and pharmacodynamics, and it is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• EVER001

Snippet

Sponsor: Everest Medicines (China) Co.,Ltd. | Conditions: Primary Membranous Nephropathy | Phase 1 | Status: RECRUITING